ex vivo-expanded autologous T cells IMA101

{
  "id": "MLC-T-ONC-013481",
  "term": "ex vivo-expanded autologous T cells IMA101",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous cytotoxic T lymphocytes, specifically recognizing certain tumor-associated antigens (TAAs), with potential antineoplastic activity. The endogenous T cells are isolated, expanded ex vivo, and reintroduced back into the patient. Upon administration, the ex vivo-expanded autologous T cells IMA101 target and kill tumor cells. The T cells are analyzed beforehand for their ability to specifically recognize certain TAAs, based on a proprietary antigen warehouse.",
  "synonyms": [
    "IMA101 T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ex-vivo-expanded-autologous-t-cells-ima101/"
}